Supreme Court to Consider Nurse Wage Case

The Supreme Court has agreed to hear a case involving a nurse’s pay and whether a defendant’s pre-certified settlement offer to a plaintiff who may bring class action is legitimate, according to a Courthouse News Service report.

Advertisement

In December 2009, Laura Symczyk sued her employer, Genesis Healthcare Corp., claiming the company violated the Fair Labor Standards Act by deducting a meal break automatically regardless of whether she took a break. In February 2010, Genesis answered Ms. Symczyk’s complaint with an offer of $7,500 in alleged unpaid wages, attorneys’ fees and other court costs, according to the report.

However, Ms. Symczyk did not respond to Genesis’ pre-certified offer as she considered class action. However, the FLSA prohibits class actions but permits collective actions, according to a Brickler & Eckler report.  

No other employee joined Ms. Symczyk in the litigation. Genesis moved to dismiss the litigation, and a district court ruled that Genesis’ initial offer “mooted the collection action and that the action should be dismissed for lack of subject matter jurisdiction,” according to the report. However, the U.S. Court of Appeals for the Third Circuit reversed the district’s decision. The Supreme Court will now rule on the case this October.

More Articles on the Supreme Court:

4 Predicted Supreme Court Rulings on the PPACA: What’s at Stake for Hospitals

Another Looming Supreme Court Ruling: The Phoebe Putney-Palmyra Deal

Billions of Dollars Riding on Supreme Court Healthcare Decision

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Legal & Regulatory Issues

Advertisement

Comments are closed.